AngioDynamics, Inc.
ANGO · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,993 | -$184,349 | -$52,442 | -$26,547 |
| Dep. & Amort. | $25,800 | $27,712 | $30,873 | $29,349 |
| Deferred Tax | -$988 | -$7,968 | -$2,311 | -$3,708 |
| Stock-Based Comp. | $9,772 | $10,529 | $11,158 | $10,692 |
| Change in WC | -$14,112 | $14,421 | -$7,026 | -$21,047 |
| Other Non-Cash | $3,393 | $111,497 | $19,826 | $4,067 |
| Operating Cash Flow | -$10,128 | -$28,158 | $78 | -$7,194 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,464 | -$2,518 | -$3,812 | -$4,297 |
| Net Acquisitions | $0 | $0 | $0 | -$3,600 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,714 | $126,235 | -$5,934 | -$11,410 |
| Investing Cash Flow | -$10,178 | $123,717 | -$9,746 | -$19,307 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$50,000 | $25,000 | $5,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,670 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,415 | -$14,248 | $420 | $2,683 |
| Financing Cash Flow | -$255 | -$64,248 | $25,420 | $7,683 |
| Forex Effect | $398 | $125 | $43 | -$518 |
| Net Chg. in Cash | -$20,163 | $31,436 | $15,795 | -$19,336 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76,056 | $44,620 | $28,825 | $48,161 |
| End Cash | $55,893 | $76,056 | $44,620 | $28,825 |
| Free Cash Flow | -$14,592 | -$33,926 | -$4,274 | -$11,491 |